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Electron microscopy of two homologous giant proteins revealed that complement factor C3 and a,-inhibitor 3 have a common structural motif 
of a semicircularly bent string 18-20 nm long with two or three bumps indicating globular domains. C3 had a structure similar to the letter C 
with a small but distinct hole in the center. a,-Inhibitor 3 was a more complete ring sometimes ajar at one comer. When the latter was treated 
with a proteinase, it became slightly flattened and adopted a squarish C-shape. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Complement factor C3 and or-inhibitor 3 are 
distantly related proteins both belonging to the 
az-macroglobulin superfamily of proteins [ 1,2]. C3 is a 
well-known major member of the complement cascade 
and made of two polypeptide chains with molecular 
masses of 110 000 and 70 000, which are the conse- 
quences of post-translational processing of a single 
polypeptide with a molecular mass of 180 000 [3], 
whereas rat or-Inhibitor 3 is made of a single chain of 
molecular mass 200 000 [4]. The function of C3 is to 
release an anaphylatoxin upon interaction with C3 con- 
vertase and expose a thiolester bond which becomes 
temporarily activated and forms a covalent bond with 
cell surface hydroxyl groups to induce the complement 
cascade which eventually brings upon lysis of the cell 
[3]. al-Inhibitor 3, on the contrary, is known as a pro- 
teinase inhibitor with a similar activity to human 
cYz-macroglobulin although its molecular mass is only 
one-fourth of the latter [4]. The thiolester bond of 
al-inhibitor 3 does not have a well-defined function, ex- 
cept that it can form a covalent bond with the inhibited 
proteinase molecule. Both proteins have not been 
studied by X-ray crystallography and elucidation of 
their gross structural features by electron microscopy is 
needed for the understanding of the structure-function 
relationship of the two distantly related proteins with 
diversified functions. 
2.1. Proteins 
Human complement C3 and rat cxi-inhibitor 3 were prepared ac- 
cording to the method of Muto et al. [5] and Saito et al. [4], respec- 
tively, and the purity was checked by polyacrylamide gel 
electrophoresis n the presense and absence of sodium dodecyl sulfate 
[6]. The proteinase inhibitory activity of al-inhibitor 3 was confirmed 
using trypsin and chymotrypsin as proteinases and azocasein as 
substrate. 
2.2. Electron microscopy 
Electron micrographs were taken on an Hitachi HU 1lB electron 
microscope (Hitachi, Japan). Purified protein samples were passed 
through a TSK G4OOOSW gel column (Tosoh) mounted on an HPLC 
system (BIP-I pump and UVIDEC 100-V monitor, Jasco, Japan) 
with 50 mM sodium phosphate @H 7.0) as elution buffer. The final 
concentration of protein samples was adjusted to be between 30 and 
100 pg/ml. A drop of protein solution was placed on a glow- 
discharged carbon-coated Formvar film formed on a copper grid and 
the excess solution was blotted. A staining solution of 3% uranyl 
acetate was then applied to the membrane and blotted. The resulting 
stained sample was dried in air and used as a negatively stained 
specimen for electron microscopy. Photographs were taken at the 
nominal magnification of x 50 000 and enlarged in printing when 
necessary. 
3. RESULTS 
3.1 Electron micrograph of complement factor C3 
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Fig. la and b show low and high magnification 
photographs of complement C3 after negative staining 
with uranyl acetate. The low magnification photograph 
in fig. la confirms that thesample was homogeneous in 
size with a clear background. When enlarged in prin- 
ting in fig.lb, C3 showed distinct structural 
characteristics resembling the letter C made of a thick 
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Fig. 1. Electron micrographs of negatively stained complement factor 
C3. Scale bars represent 30 nm. 
string. The outer diameter of the molecules is about 
lo-12 nm. The thickness of the string is not constant, 
less than 2 nm in thinner parts and close to 5 nm where 
it is thick. The string-like main body is thus divided into 
at least three semiglobular domains. The central cavity 
is about 2-3 nm in diameter and directly open to the 
outside. The shape of the molecule is similar to the 
results of Dahlback et al. ]7] on the proteinase-treated 
C4, another homolog of atz-macroglobulin, but the cen- 
tral cavity is more pronounced in our result. 
3.2. Electron micrograph of w-inhibitor 3 
Fig.2a shows a low magnification photograph of 
~~-inhibitor 3 after the same treatment as above and 
confirms the homogeneity and cleanness of the sample. 
Fig.2b and c show, respectively, high magnification 
photographs of al-inhibitor 3 before and after the reac- 
tion with chymotrypsin. The native molecules in fig.2b 
look like closed rings but some of them are slightly ajar 
in one site. The diameter of the molecule is about 10 nm 
and that of the central hole is 2-3 nm. The ring struc- 
ture often shows at least three globular domains as was 
the case for C3. The structure of or-inhibitor 3 is very 
similar to that of complement C3 except that the 
former looks like a more closed ring. After reaction 
with chymotrypsin, cur-inhibitor 3 became more 
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Fig.2. Electron micrographs of negatively stained al-inhibitor 3. 
Before interaction with chymotrypsin (a and bf and after (c). The 
same magnification factors apply for b and c. Scale bars represent 
30 nm. 
squarish and more open to the outside with a distinct 
channel connecting the inner cavity to the outer space. 
The presence of proteinase molecules within 
al-inhibitor 3 could not be confirmed by electron 
microscopy. 
4. DISCUSSION 
The electron micrographs of the two homologous 
proteins showed similar semicircular forms with a small 
hole in the center. In the case of complement C3, the 
string formed a thick C with a clear opening and a 
distinct hole in the center but in Al-inhibitor 3, the 
polypeptide formed a closed ring but its proteinase 
treatment revealed a basic string unit similar to the one 
found in C3. Proteinase treatment of this protein 
cleaves only a limited number of peptide bonds in the 
bait region sequence and opening of the closed ring 
represents the major conformational change responsi- 
ble for the binding of a proteinase molecule. Since, in 
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C3, the original giant polypeptide is aiready processed REFERENCES 
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and split into two chains, aithough not exactly at the 
same position as the bait region of al-inhibitor 3, it is 
reasonable that the structure of proteinase-treated 
cq-inhibitor 3 corresponded better to that of C3. In 
both cases, it was possible to detect two or three 
semig~obular domains and functions identification of 
them using immunoelectron microscopy will be essen- 
tial to understand the structure-function reiationship of 
these proteins. 
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